{"id":1016392,"date":"2026-11-02T17:33:11","date_gmt":"2026-11-02T22:33:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/"},"modified":"2026-11-02T17:33:11","modified_gmt":"2026-11-02T22:33:11","slug":"myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/","title":{"rendered":"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SALT LAKE CITY, Nov.  02, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Wodud-BQjWPa21AbOZOkeO0ARfGiotVO4rJchBISh0yjpaPpAWgzcpZXykDxZO_BIxeS8doXkisTmb5_yLppKX-TWgjgtKoj0UyheEUB9kE=\" rel=\"nofollow\" target=\"_blank\">Myriad Genetics, Inc<\/a>. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that Myriad management will participate in three upcoming healthcare conferences.<\/p>\n<ul type=\"disc\">\n<li>The UBS Global Healthcare Conference with a fireside chat on Tuesday, Nov. 10, 2026, at 1:15 pm ET.\n<\/li>\n<li>The 2026 Stephens Investment Conference with a fireside chat on Wednesday, Nov. 18, 2026, at 3:00 pm ET.\n<\/li>\n<li>The 38<sup>th<\/sup> Annual Piper Sandler Healthcare Conference with a fireside chat on Wednesday, Dec. 2, 2026, at 12:30 pm ET.<\/li>\n<\/ul>\n<p>The presentations will be available through live audio webcast links in the investor information section of Myriad\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XjfddX-5Xp0jIyP-lMLx0RwYUwLxhXpMp6bq8d5bGb1AZYaVQZfRR-10rYtr9O9UY1wkFDZqKNmiI4VgwXEzIs7OcBGLK756HxD5EB9qVVs=\" rel=\"nofollow\" target=\"_blank\">investor.myriad.com.<\/a>\u00a0<\/p>\n<p>\n        <strong>About Myriad Genetics<\/strong>\n      <\/p>\n<p>Myriad Genetics is a leading molecular diagnostic and precision medicine company committed to advancing health and well-being for all. Myriad Genetics develops and commercializes molecular tests that help patients and providers uncover genetic insights. Our tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care, support earlier detection, enable more precise treatment and contribute to lowering healthcare costs. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PrkR4J_Fj7duYwcoWkR4D14Mo1FcK77wzAg3l1Dd8fbWNIBiUgLN3iuEsJuHoHqXkqDSd7ibzjqu8mHaSCe2rw==\" rel=\"nofollow\" target=\"_blank\">www.myriad.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact\u00a0<\/strong><br \/>\n        <br \/>Matt Scalo\u00a0<br \/>(801) 584-3532\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-BGTYCqT6xrGZiUJEbW0xuqoXPo_FzJwMkfp092qpMYXH9GMihyyZYNBd6itxOIOB9NEt5uzVcYoEkEH5g0wVw==\" rel=\"nofollow\" target=\"_blank\"><u>IR@myriad.com<\/u><\/a>\u00a0<\/p>\n<p>\n        <strong>Media Contact\u00a0<\/strong><br \/>\n        <br \/>Andria Rosell<br \/>(385) 202-3510 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zsgpya96ocnPr3zu8mv23THAQs5A939jq8JXShrjja3Vu30goDFNt-gRdtfsCrAitlUHvCwst8t9cbXcwLt5Dg==\" rel=\"nofollow\" target=\"_blank\">PR@myriad.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODA4NyM3OTM5NjgyIzIwMDc4ODc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTY2YmE3MWYtMmYwYi00NjU4LTk4MDgtMWI3MmE1N2VhYmFiLTEwMTk0NjAtMjAyNi0xMS0wMi1lbg==\/tiny\/Myriad-Genetics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SALT LAKE CITY, Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that Myriad management will participate in three upcoming healthcare conferences. The UBS Global Healthcare Conference with a fireside chat on Tuesday, Nov. 10, 2026, at 1:15 pm ET. The 2026 Stephens Investment Conference with a fireside chat on Wednesday, Nov. 18, 2026, at 3:00 pm ET. The 38th Annual Piper Sandler Healthcare Conference with a fireside chat on Wednesday, Dec. 2, 2026, at 12:30 pm ET. The presentations will be available through live audio webcast links in the investor information section of Myriad\u2019s website at investor.myriad.com.\u00a0 About Myriad Genetics Myriad Genetics is a leading molecular &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1016392","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SALT LAKE CITY, Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that Myriad management will participate in three upcoming healthcare conferences. The UBS Global Healthcare Conference with a fireside chat on Tuesday, Nov. 10, 2026, at 1:15 pm ET. The 2026 Stephens Investment Conference with a fireside chat on Wednesday, Nov. 18, 2026, at 3:00 pm ET. The 38th Annual Piper Sandler Healthcare Conference with a fireside chat on Wednesday, Dec. 2, 2026, at 12:30 pm ET. The presentations will be available through live audio webcast links in the investor information section of Myriad\u2019s website at investor.myriad.com.\u00a0 About Myriad Genetics Myriad Genetics is a leading molecular &hellip; Continue reading &quot;Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-02T22:33:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODA4NyM3OTM5NjgyIzIwMDc4ODc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences\",\"datePublished\":\"2026-11-02T22:33:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\\\/\"},\"wordCount\":210,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2ODA4NyM3OTM5NjgyIzIwMDc4ODc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\\\/\",\"name\":\"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2ODA4NyM3OTM5NjgyIzIwMDc4ODc=\",\"datePublished\":\"2026-11-02T22:33:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2ODA4NyM3OTM5NjgyIzIwMDc4ODc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2ODA4NyM3OTM5NjgyIzIwMDc4ODc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/","og_locale":"en_US","og_type":"article","og_title":"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk","og_description":"SALT LAKE CITY, Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that Myriad management will participate in three upcoming healthcare conferences. The UBS Global Healthcare Conference with a fireside chat on Tuesday, Nov. 10, 2026, at 1:15 pm ET. The 2026 Stephens Investment Conference with a fireside chat on Wednesday, Nov. 18, 2026, at 3:00 pm ET. The 38th Annual Piper Sandler Healthcare Conference with a fireside chat on Wednesday, Dec. 2, 2026, at 12:30 pm ET. The presentations will be available through live audio webcast links in the investor information section of Myriad\u2019s website at investor.myriad.com.\u00a0 About Myriad Genetics Myriad Genetics is a leading molecular &hellip; Continue reading \"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-02T22:33:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODA4NyM3OTM5NjgyIzIwMDc4ODc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences","datePublished":"2026-11-02T22:33:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/"},"wordCount":210,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODA4NyM3OTM5NjgyIzIwMDc4ODc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/","name":"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODA4NyM3OTM5NjgyIzIwMDc4ODc=","datePublished":"2026-11-02T22:33:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODA4NyM3OTM5NjgyIzIwMDc4ODc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODA4NyM3OTM5NjgyIzIwMDc4ODc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016392","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1016392"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016392\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1016392"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1016392"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1016392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}